Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder

NCT: NCT05160129 · RECRUITING

NCT IDNCT05160129
StatusRECRUITING
Start Date2021-08-13
Completion2027-02-28
SponsorIcahn School of Medicine at Mount Sinai (OTHER)
First posted
Last updated

Brief Summary

Deep brain stimulation (DBS) is an effective treatment for people suffering from severe obsessive-compulsive disorder (OCD) whose symptoms have failed to improve after years and multiple methods of intervention. An effective DBS target for OCD is the anterior limb of the internal capsule (ALIC) brain region. On average 60% of all OCD patients have a clinically significant response to ALIC DBS. However, ALIC DBS may become even more effective with the ability to predict which specific ALIC connections in the brain need to be stimulated for each individual OCD patient. This study therefore investigates personalized stimulation to the ALIC that allows for precise modulation of brain circuits associated with individual OCD symptoms. The study aims to specify the ideal anatomical target for ALIC DBS for maximum therapeutic benefit in each patient.

Frequently Asked Questions

What is Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder?

Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder is a clinical trial registered under NCT05160129. Current status: RECRUITING.

What is the status of NCT05160129?

The current status of NCT05160129 (Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder) is: RECRUITING.

When did Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder start?

Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder started on 2021-08-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.